Insulin

DOWNEY, Calif. (AP) — The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce… DOWNEY,…

California Gov. Gavin Newsom announced Saturday that the state has launched a 10-year partnership with a drug maker to produce insulin for its residents at a significantly lower cost.The state plans to sell insulin at a cost of $30…

SACRAMENTO — Gov. Gavin Newsom on Saturday announced the selection of Utah-based generic drug manufacturer Civica to produce low-cost insulin for California, an unprecedented move that makes good on his promise to put state government in…

Gov. Gavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey.Newsom originally declared his intent to produce…

California will cut patients’ cost for insulin by 90% to $30, regardless of their insurance plan, Gov. Gavin Newsom announced Saturday. The state has a contract with non-profit generic-drug company Civica to manufacture insulin, a hormone…

Gov. Gavin Newsom announced a new state contract on Saturday morning, March 18, that officials say will leverage the state’s generic drug label to bring $30 insulin to California, cutting costs for the medicine by 90% — while saving…

According to a new study, an artificial pancreas created at the University of Virginia Center for Diabetes Technologies improves blood sugar management in children aged 2 to 6 with type 1 diabetes. The clinical study's details and…

By Keith Roach, M.D. on Mar 17, 2023 DEAR DR. ROACH: My husband is an over-the-road truck driver, and he is 68. He has been on metformin for a long time, and I have been reading that this medicine does not help bring down blood sugar.…

Topline Pharmaceutical giant Sanofi announced Thursday it will cut the price of its most commonly prescribed insulin by 78% and cap the monthly cost at $35, becoming the latest drug maker—behind Eli Lilly and Novo Nordisk—to slash insulin…

French pharmaceutical company Sanofi, one of the top three insulin manufacturers for the U.S., announced on Thursday it would be cutting the list price for its most prescribed insulin product Lantus by 78 percent, joining fellow major…